Stay updated on PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Sign up to get notified when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.
Latest website image capture
Clouds background image

Latest updates to the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is displayed, replacing v3.3.1. No substantive study information appears to have changed.
    Difference
    0.1%
    Check dated 2025-12-01T15:11:46.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and Revision: v3.2.0 was removed, a metadata update with no change to trial content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:01:19.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page. This does not affect the study details, eligibility criteria, or trial timelines.
    Difference
    0.4%
    Check dated 2025-11-17T06:08:07.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Both screenshots show the same study details and status; there are no additions or deletions to core content such as the trial title, conditions, eligibility, or outcomes.
    Difference
    0.4%
    Check dated 2025-11-03T00:45:03.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Core page content updated with a government operating status notice and a new resource topic; software revision updated from v3.1.0 to v3.2.0. No other significant changes.
    Difference
    3%
    Check dated 2025-10-05T06:34:39.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Major change: version updated to v3.1.0 with removal of a specific disease resource (Diffuse large B-cell lymphoma) from the Genetics and Rare Diseases Information Center; no new substantive content added.
    Difference
    0.5%
    Check dated 2025-09-28T02:51:39.000Z thumbnail image

Stay in the know with updates to PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Enter your email address, and we'll notify you when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.